27 results on '"Murray, David L."'
Search Results
2. Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
3. Relationship and Susceptibility to Serious Infections Among Monoclonal B-Cell Lymphocytosis (MBL), Monoclonal Gammopathy of Undetermined Significance (MGUS), and Clonal Hematopoiesis (CH) Premalignant Conditions
4. Tracking Daratumumab Clearance Using Mass Spectrometric Approaches: Implications on M Protein Monitoring and Reusing Daratumumab
5. The Prognostic Utility of Serial MASS-FIX in Multiple Myeloma
6. High Prevalence of Monoclonal Gammopathy in a Population at Risk: The First Results of the Promise Study
7. Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
8. Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes
9. ELISA-Negative Platelet-Activating Anti-PF4 Antibodies Can Cause HIT and Monoclonal Gammopathy of Thrombotic Significance (MGTS)
10. A Cross Sectional Evaluation of Light Chain N-Glycosylation By MASS-FIX in Plasma Cell Disorders
11. Sequential Comparison of Conventional Serum Immunofixation (IFE) to Mass Spectrometry-Based Assessment (MASS FIX) in Patients with Multiple Myeloma (MM)
12. Detection of Monoclonal Immunoglobulin By Mass Spectrometry in Patients Evaluated for Thrombotic Microangiopathy (TMA)
13. MASS-FIX for the Diagnosis of Plasma Cell Disorders: A Single Institution Experience of 4118 Patients
14. Comparison of MGUS Prevalence By Race and Family History Risk Groups Using a High Sensitivity Screening Method (MASS-FIX)
15. A universal solution for eliminating false positives in myeloma due to therapeutic monoclonal antibody interference
16. Immunoglobulin Variable Gene Region (IGVL) Usage Correlates with Distinct Clinical Presentation in IgM Versus Non-IgM Light Chain Amyloidosis
17. Prognostic Implications of Serum Monoclonal Protein Positivity By Mass-Fix in Bone Marrow Minimal Residual Disease Negative (MRD-) Patients with Multiple Myeloma
18. Glycosylation of Immunoglobulin Light Chains Is Highly Prevalent in Cold Agglutinin Disease
19. Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL)
20. A Rapid MALDI-TOF Method for Isotyping and Quantitating M-Proteins in a Single Assay: Longitudinal Comparison to Serum Protein Electrophoresis and Hevylite for Monitoring Patients with Monoclonal Gammopathies
21. Novel Genetic Variants in Complement-Mediated Thrombotic Microangiopath
22. Evaluating Pembrolizumab Interference with Monoclonal Protein Detection By Immunofixation and By MALDI-TOF Mass Spectrometry (MASS-FIX)
23. Atypical Hemolytic Uremic Syndrome-Clinical Presentation, Treatment, and Short Term Outcomes: The Mayo Clinic Experience
24. High Sensitivity Detection of Malignant-Specific M-Proteins Using Mass Spectrometry
25. Monitoring Minimum Residual Disease In Multiple Myeloma Patients By LC-MS/MS
26. Proteomic Analysis of Immunoglobulin Light Chains (LC) In AL Amyloidosis Shows That the Sequence of Clonal LC Secreted by the Neoplastic Plasma Cells Is Identical to the LC Deposited In the Amyloid Plaques
27. Comparison of progression risk of monoclonal gammopathy of undetermined significance by method of detection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.